IRIS
FREDIANI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.779
EU - Europa 29.984
AS - Asia 18.259
SA - Sud America 3.369
AF - Africa 1.012
OC - Oceania 68
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 86.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.137
IT - Italia 7.013
RU - Federazione Russa 6.242
SG - Singapore 5.910
GB - Regno Unito 5.680
CN - Cina 5.206
IE - Irlanda 2.869
BR - Brasile 2.789
VN - Vietnam 2.019
DE - Germania 1.674
FR - Francia 1.482
SE - Svezia 1.461
HK - Hong Kong 1.460
UA - Ucraina 1.315
KR - Corea 952
FI - Finlandia 927
BD - Bangladesh 703
IN - India 600
ZA - Sudafrica 471
CA - Canada 349
NL - Olanda 305
TR - Turchia 200
AR - Argentina 196
ES - Italia 187
IQ - Iraq 179
JP - Giappone 174
MX - Messico 166
PL - Polonia 161
CI - Costa d'Avorio 134
PK - Pakistan 115
CZ - Repubblica Ceca 106
AT - Austria 104
EC - Ecuador 100
ID - Indonesia 95
KE - Kenya 78
UZ - Uzbekistan 76
NG - Nigeria 74
MA - Marocco 73
BE - Belgio 67
VE - Venezuela 63
AU - Australia 59
SA - Arabia Saudita 59
CL - Cile 57
CH - Svizzera 56
IR - Iran 55
AE - Emirati Arabi Uniti 52
CO - Colombia 49
PH - Filippine 49
EG - Egitto 45
LT - Lituania 44
PY - Paraguay 42
JO - Giordania 40
GR - Grecia 36
NP - Nepal 35
RO - Romania 35
TN - Tunisia 34
PE - Perù 33
MY - Malesia 32
JM - Giamaica 29
IL - Israele 27
DZ - Algeria 26
UY - Uruguay 25
AZ - Azerbaigian 24
PT - Portogallo 23
DK - Danimarca 21
KZ - Kazakistan 20
LB - Libano 20
BY - Bielorussia 19
CR - Costa Rica 18
ET - Etiopia 18
AL - Albania 17
BG - Bulgaria 16
EE - Estonia 16
HU - Ungheria 16
LV - Lettonia 16
TW - Taiwan 16
EU - Europa 15
PS - Palestinian Territory 15
DO - Repubblica Dominicana 14
KG - Kirghizistan 14
OM - Oman 13
PA - Panama 13
AM - Armenia 12
SN - Senegal 12
HN - Honduras 11
RS - Serbia 11
SK - Slovacchia (Repubblica Slovacca) 11
TH - Thailandia 11
CY - Cipro 10
NO - Norvegia 10
SY - Repubblica araba siriana 10
BO - Bolivia 9
HR - Croazia 9
BH - Bahrain 8
KW - Kuwait 8
LY - Libia 8
NI - Nicaragua 8
NZ - Nuova Zelanda 8
QA - Qatar 8
SV - El Salvador 8
Totale 86.347
Salva come PNG Salva come JPEG
Città #
Dallas 6.275
Southend 4.886
Singapore 3.558
Dublin 2.825
Ashburn 2.480
Fairfield 2.319
Milan 1.729
Moscow 1.718
Santa Clara 1.608
San Jose 1.540
Chandler 1.390
Hong Kong 1.351
Hefei 1.341
Woodbridge 1.184
Beijing 1.091
Jacksonville 991
Seoul 945
Wilmington 941
Council Bluffs 928
Houston 876
Seattle 847
Cambridge 790
Siena 763
Menlo Park 716
Los Angeles 715
Rome 711
Ann Arbor 650
Ho Chi Minh City 613
New York 575
The Dalles 551
Helsinki 521
Munich 518
Hanoi 486
Princeton 461
Lauterbourg 455
Johannesburg 417
Nanjing 318
São Paulo 275
Florence 265
Buffalo 230
Bengaluru 212
Boardman 201
San Mateo 199
Orem 175
Chicago 170
San Diego 164
Redondo Beach 145
London 141
Shanghai 136
Frankfurt am Main 135
Abidjan 134
Columbus 131
Dearborn 130
Turin 126
Warsaw 123
Tokyo 121
Figino 117
Dong Ket 114
Lappeenranta 112
Montreal 112
Turku 109
Nanchang 107
Düsseldorf 102
Naples 100
Atlanta 99
Chennai 93
Denver 91
Nuremberg 91
Toronto 90
Da Nang 88
Haiphong 85
Shenyang 85
Rio de Janeiro 84
Brooklyn 83
Guangzhou 82
Stockholm 82
Lancaster 80
San Francisco 76
Málaga 74
Washington 74
Bologna 73
Abuja 70
Baghdad 70
Phoenix 69
Tashkent 65
Tianjin 64
Belo Horizonte 63
Hebei 63
Mexico City 63
Changsha 61
Boston 60
Poplar 60
Vienna 60
Amsterdam 58
Izmir 55
Jiaxing 55
Manchester 55
Olomouc 55
Portsmouth 55
Brussels 54
Totale 56.754
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 901
A first update on mapping the human genetic architecture of COVID-19 589
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 587
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 523
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 505
A new integrated and interactive tool applicable to inborn errors of metabolism: Application to alkaptonuria 486
Genetic mechanisms of critical illness in COVID-19 434
Ultrasound definition of subacromial chronic “fibro-adhesive” bursitis and its treatment via ultrasound guided hydrodilation: a prospective pilot study 427
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 426
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 408
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. 377
Histological and Ultrastructural Characterization of Alkaptonuric Tissues 376
An explainable model of host genetic interactions linked to COVID-19 severity 375
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 372
A "new" technique for the diagnosis of chondrocalcinosis of the knee: sensitivity and specificity of high-frequency ultrasonography 369
Antirheumatic agents in covid-19: is IL-6 the right target? 366
Pathogen-sugar interactions revealed by universal saturation transfer analysis 363
Establishment of Four New Human Primary Cell Cultures from Chemo-Naïve Italian Osteosarcoma Patients 358
AB0969 Accuracy of blind intra-articular injections in patients with osteoarthritis of the knee. An ultrasonography controlled study 358
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 357
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 353
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 350
Angiogenesis in alkaptonuria 346
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 344
AB0535 Effects of tocilizumab on bone density and metabolism in patients with active rheumatoid arthritis 336
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 323
Bone mineral density in patients with systemic sclerosis. 323
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 320
null 320
Peripheral biomarkers' panel for severe COVID-19 patients 320
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 318
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 317
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 317
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 316
Change perspective to increase diagnostic accuracy of ultrasonography in calcium pyrophosphate dehydrate deposition disease! A new approach: The axial scan of the meniscus 312
Deltoideal acromial enthesopathy in ankylosing spondylitis and in spondylarthropathies: comment on the article by Lambert et al. 311
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 308
Long-term effects of neridronate on human osteoblastic cell cultures 307
A proteomic study of human osteoblastic cells proliferation and differentiation 306
AB1308 Prevalence of baker’s CYST in patients with chronic gonalgia and relationship with major non inflammatory diseases 303
Spasmophilia and entrapment nerve syndrome comorbidities in fibromyalgic patients: a possible neuromuscular pain generator. 303
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 302
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes 302
Cytoskeleton Aberrations in Alkaptonuric Chondrocytes 301
Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound 300
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 299
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 297
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 297
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 296
Comparative proteomics in alkaptonuria provides insights into inflammation and oxidative stress 295
Diagnosis of calcium pyrophosphate dihydrate crystal deposition disease: ultrasonographic criteria proposed. 293
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 291
Ultrasonography and magnetic resonance imaging of heel fat pad inflammatory-oedematous lesions in rheumatoid arthritis 288
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 286
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 285
FRI0501 Ultrasound versus synovial fluid analysis for the diagnosis of calcium pyrophosphate dihydrate deposition disease: preliminary results 285
A randomized comparison of the acceleraded folinic acid and 5-fluorouracil versus the conventional 5-fluorouracil schedule in advanced colorectal cancer. Supportive care and quality of life. 282
Efficacy of Cellfood's therapy (deutrosulfazyme) in fibromyalgia [Efficacia del trattamento con Cellfood (deutrosulfazyme) nella fibromialgia] 279
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 279
Radiologists and rheumatologists on performing and reporting shoulder ultrasound: From disagreement to consensus 278
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 278
Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis 275
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 272
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 271
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 270
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 269
Clodronate in the management of different musculoskeletal conditions 268
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 268
Extent and distribution of CPP deposits in patients affected by calcium pyrophosphate dihydrate deposition disease: An ultrasonographic study 267
Calcaneus ultrasonometry and dual-energy X-ray absorptiometry for the evaluation of vertebral fracture risk 265
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 264
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 262
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 261
Sonographic and electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. 260
Efficacy of extracorporeal shock wave treatment in calcaneal enthesophytosis. 259
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)] 259
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 259
SAT0312 Ultrasound Reliability in the Diagnosis of Calcium Pyrophosphate Deposition Disease: Agreement Between Observers and Main Causes of Discordance 258
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 257
Prognostic bioindicators in severe COVID-19 patients 257
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 257
Comment on: longitudinal examination with shoulder ultrasound in patients with polymyalgia rheumatica. 256
FRI0533 Ultrasonographic Features of Joints and Entheses in Healty Children 251
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation 250
Serial KL-6 measurements in COVID-19 patients 250
Extracorporeal shock wave therapy in the treatment of inferior calcaneal enthesophytosis: outcome by fan-beam dual x ray absorptiometry (DXA). 248
Weekly oral alendronate in mevalonate kinase deficiency 248
SAT0542 The Prevalence of Calcium Pyrophosphate Deposits at Ultrasound Examination: Retrospective Analysis in A Cohort of Patients 247
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 245
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 244
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 243
Clodronate: New directions of use 242
SAT0315 Calcium Pyrophosphate Dihydrate Deposition Disease: A Proposal of New Ultrasonographic Criteria for CPP Identification in the Joints 242
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 241
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 241
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 241
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 240
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 239
SAT0530 The Useful of us in Diagnosis of Carpal Tunnel Syndrome in Diabetics: a Proposal for New Reference Values 237
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 237
Totale 31.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 253.722
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 253.722
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.487 383 537 307 350 260 176 195 201 272 459 476 871
2022/20235.445 361 434 683 722 439 1.077 253 442 509 152 221 152
2023/20245.237 208 158 482 288 257 1.282 1.566 198 48 137 162 451
2024/202514.668 560 781 1.643 796 1.560 860 733 885 1.087 731 1.430 3.602
2025/202638.220 2.538 5.281 5.036 4.395 6.464 1.430 4.023 1.130 1.366 1.886 1.374 3.297
2026/20271.134 1.134 0 0 0 0 0 0 0 0 0 0 0
Totale 87.944